Exchange: NASDAQ·Updated 07:30 PM EDT
DXR logo

DXR Daxor Corp.

$10.36
$0.1207
(1.18%)
Today
Closed $10.08
$0.2807
(2.79%)
After Hours
Mkt Cap$35.55M
Vol871.00

About DXR

DAXOR Corporation is an innovative medical instrumentation and biotechnology company. DAXOR designed and developed the BVA-100 Blood Volume Analyzer. It is the first instrument approved by the FDA to provide rapid direct measurement of a patient's true blood volume. We believe that the BVA-100 Blood Volume Analyzer has the potential to transform therapy in a broad range of surgical and medical conditions. It is our goal, working in conjunction with hospitals and clinics, to achieve that possibility. The BVA-100 is a semi-automated Blood Volume Analyzer. It is used in conjunction with a single use diagnostic kit. It is the first FDA-approved instrument to provide rapid direct measurement of a patient's blood volume.
62

Bullish Sentiment

How do you feel about DXR?

Advertisement|Remove ads.